Search research articles
Contact Us
Filters
Showing results (81-90 of 296) with videos related to
Page
of 30
Sort By:
Pigment Cell & Melanoma Research
|
July 12, 2024
Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma
Mael Lever, Simon Bogner, Melina Giousmas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 29, 2021
HER2 mediates clinical resistance to the KRAS<sup>G12C</sup> inhibitor sotorasib, which is overcome by co-targeting SHP2
Cassandra S L Ho, Alicia I Tüns, Hans-Ulrich Schildhaus, et al.
JCO Precision Oncology
|
February 9, 2022
Dramatic Response of a PD-L1-Positive Advanced Angiosarcoma of the Scalp to Pembrolizumab
Rainer Hamacher, Dietrich Kämpfe, Kirsten Reuter-Jessen, et al.
Cells
|
October 28, 2025
Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression
Luca Hegedüs, Silvia Qaisieh, Christian Stülpnagel, et al.
Cells
|
October 23, 2021
An Oil Hyper-Accumulator Mutant Highlights Peroxisomal ATP Import as a Regulatory Step for Fatty Acid Metabolism in <i>Aurantiochytrium limacinum</i>
Etienne Deragon, Martin Schuler, Riccardo Aiese Cigliano, et al.
Cancer Research
|
August 27, 2009
Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors
Thomas Mühlenberg, Yixiang Zhang, Andrew J Wagner, et al.
Analytical Chemistry
|
September 5, 2019
Fast and Noninvasive Diagnosis of Cervical Cancer by Coherent Anti-Stokes Raman Scattering
Karim Aljakouch, Ziad Hilal, Ibrahim Daho, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2018
A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer
Ugur Sahin, Martin Schuler, Heike Richly, et al.
The Journal of Cell Biology
|
January 8, 2004
Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation
Clare L Scott, Martin Schuler, Vanessa S Marsden, et al.
Integrative Cancer Therapies
|
January 24, 2023
Neurofeedback Treatment Affects Affective Symptoms, But Not Perceived Cognitive Impairment in Cancer Patients: Results of an Explorative Randomized Controlled Trial
Madeleine Fink, Saskia Pasche, Kira Schmidt, et al.
Page
of 30
Search research articles
Search
Showing results (81-90 of 296) with videos related to
Sort By:
Page
of 30
Pigment Cell & Melanoma Research
|
July 12, 2024
Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma
Mael Lever, Simon Bogner, Melina Giousmas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 29, 2021
HER2 mediates clinical resistance to the KRAS<sup>G12C</sup> inhibitor sotorasib, which is overcome by co-targeting SHP2
Cassandra S L Ho, Alicia I Tüns, Hans-Ulrich Schildhaus, et al.
JCO Precision Oncology
|
February 9, 2022
Dramatic Response of a PD-L1-Positive Advanced Angiosarcoma of the Scalp to Pembrolizumab
Rainer Hamacher, Dietrich Kämpfe, Kirsten Reuter-Jessen, et al.
Cells
|
October 28, 2025
Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression
Luca Hegedüs, Silvia Qaisieh, Christian Stülpnagel, et al.
Cells
|
October 23, 2021
An Oil Hyper-Accumulator Mutant Highlights Peroxisomal ATP Import as a Regulatory Step for Fatty Acid Metabolism in <i>Aurantiochytrium limacinum</i>
Etienne Deragon, Martin Schuler, Riccardo Aiese Cigliano, et al.
Cancer Research
|
August 27, 2009
Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors
Thomas Mühlenberg, Yixiang Zhang, Andrew J Wagner, et al.
Analytical Chemistry
|
September 5, 2019
Fast and Noninvasive Diagnosis of Cervical Cancer by Coherent Anti-Stokes Raman Scattering
Karim Aljakouch, Ziad Hilal, Ibrahim Daho, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 25, 2018
A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer
Ugur Sahin, Martin Schuler, Heike Richly, et al.
The Journal of Cell Biology
|
January 8, 2004
Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation
Clare L Scott, Martin Schuler, Vanessa S Marsden, et al.
Integrative Cancer Therapies
|
January 24, 2023
Neurofeedback Treatment Affects Affective Symptoms, But Not Perceived Cognitive Impairment in Cancer Patients: Results of an Explorative Randomized Controlled Trial
Madeleine Fink, Saskia Pasche, Kira Schmidt, et al.
Page
of 30